- Drugs
- Wednesday, 02 Aug 2023
Clinic Casting and Splinting Products Market is expected to reach US$ 2,085.57 million by 2030
Casting Segment Held Larger Share of Clinic Casting and Splinting Products Market by Product
According to our new research study on "Clinic Casting and Splinting Products Market Size and Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product, Application, and Material," the market was valued at US$ 1,383.42 million in 2022 and is expected to reach US$ 2,085.57 million by 2030. It is estimated to register a CAGR of 5.3% during 2022–2030.
Orthopedic devices such as casts and splints are used to support and protect broken or injured bones and joints. To keep the broken bone in place while it heals completely, they assist in immobilizing the afflicted limb. Due to swelling in the injured area, splints are used immediately. A full cast may be put on the wounded limb once the swelling has reduced. Depending on the specific fracture type, the splint or cast may be worn from a few days to a couple of months. The main function of the cast is to maintain rigid alignment of bones as the body heals them over the course of several weeks or months.
Clinic Casting and Splinting Products Market, by Product, 2022-2030 (%)
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00008646
Source: The Insight Partners Analysis
Based on product, the clinic casting and splinting products market is segmented into casting and splinting. In 2022, the casting segment accounted for a larger clinic casting and splinting products market share. However, the splinting segment is anticipated to register a higher CAGR during the forecast period. The major driving factors the growth of the casting segment is because when it comes to serious fractures, orthopedic casts are usually the best option. They are typically made from stronger materials than splints, making them more durable and less likely to break or come loose. A cast can be molded specifically as per the fracture's needs and worn for several weeks as needed. The cast is more rigid than the temporary splint, but both may feel heavy.
Impact of COVID-19 Pandemic on Clinic Casting and Splinting Products Market
During the COVID-19 pandemic, many countries imposed lockdowns to avoid the spread of novel coronavirus that causes COVID-19. As a result, there was a decrease in road accidents and workplace accidents, which dropped the number of fractures, sprains, and ligament damage cases. This hampered the clinic casting and splinting products market growth during the COVID-19 pandemic. However, due to an upsurge in home accidents caused by various reasons such as falls at home, cases of fractures or sprains increased during this period. This gradually increased the demand for clinic and splinting products.
DeRoyal Industries Inc, Prime Healthcare Services Inc, 3M Co, Corflex Inc, Essity AB, Dynatronics Corporation, Zimmer Biomet Holdings Inc, Ossur hf, Performance Health Holding Inc, and Enovis Corp are among the leading companies operating in the clinic casting and splinting products market.
The report segments the clinic casting and splinting products market as follows:
The clinic casting and splinting products market is segmented on the basis of product, application, and material. Based on product, the market is bifurcated into casting and splinting. In 2022, the casting segment accounted for a larger clinic casting and splinting products market share. In terms of application, the clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. Based on material, the clinic casting and splinting products market is segmented into fiberglass, plaster of Paris, and others. Geographically, the clinic casting and splinting products market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Moderna picks drugmaker Catalent to manufacture potential COVID-19 vaccine
Jun 25, 2020
Chronic Cough Market Key Factors and Emerging Opportunities with Current Trends Analysis 2027
Jul 13, 2020
Vaccines: A Powerful Panacea to Impound Epidemic
Aug 19, 2019
North America Vaccines Market is Estimated to Grow with a CAGR of 6.0% from 2019-2027
Sep 25, 2020
Monoclonal Antibody Therapeutics (mABs) Market is expected to reach US$ 542.80 billion by 2030
Feb 05, 2024
Genentech’s Fenebrutinib Shows Breakthrough MS Results
Feb 16, 2026
New CBD Company, InnerGreen CBD, Paves the Way for Science-Based CBD
Jun 11, 2020